Ionis to hold first quarter 2023 financial results webcast
Webcast scheduled for
The webcast may be accessed at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision to become the leader in genetic medicine, utilizing a multi-platform approach to discover, develop and deliver life-transforming therapies.
To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-first-quarter-2023-financial-results-webcast-301802455.html
Ionis Pharmaceuticals Investor Contact: D. Wade Walke, Ph.D. - firstname.lastname@example.org - 760-603-2331; Ionis Pharmaceuticals Media Contact: David Polk, J.D. - email@example.com - 760-603-4679